✦ LIBER ✦

UNMAINTAINED TRILINEAGE RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN IN A PATIENT WITH MYELODYSPLASIA

✍ Scribed by Doug Jones; Zella R. Zeigler; Craig S. Rosenfelo; Richard K. Shadduck

Book ID: 114712949
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 180 KB
Volume: 80
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1992.tb08152.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trilineage response to recombinant human

Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome

✍ Caroline Rey; Brigiette Bader-Meunier; Gérard Tertian; Francçise Mielot; Gil Tch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

Effect of subcutaneously administered hu

Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia

✍ Harmen van Kamp; Tineke C. Prinsze-Postema; Philip M. Kluin; Gerard J. Den Ottol 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Response to recombinant human erythropoi

Response to recombinant human erythropoietin (rHuEpo) in patients with cancer-related anaemia

✍ Pedrazzoli, P.; Ponchio, L.; Poggi, G.; Preti, P.; Rosti, V.; Cazzola, M.; Robus 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Vascular changes in hemodialysis patient

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin

✍ London, Gérard M; Zins, Brigitte; Pannier, Bruno; Naret, Catherine; Berthelot, J 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 526 KB

Trilineage recovery by combination thera

Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia

✍ Masami Bessho; Itsuro Jinnai; Kunitake Hirashima; Masanobu Saito; Ikuo Murohashi 📂 Article 📅 1994 🏛 AlphaMed Press 🌐 English ⚖ 819 KB

Response predicting factors to recombina

Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy

✍ Manolo González-Barón; Amdio Ordóñez; Rosa Franquesa; Manuel Constenla; Joaquin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Background: The response to epoetin-alpha treatment is hard to predict in cancer patients receiving chemotherapy. ## Methods: One hundred and seventeen patients were enrolled in this observational study. they had a hemoglobin (hb) level less than or equal to 10.5 g/dl, were receiving platinum